USPTO serial 86300715
ATGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SONNEBORN, TRICIA L
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ATGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do 463-400, KR
Gyeonggi-do 463-400, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margaret C. McHugh
GIA CINCONE KILPATRICK TOWNSEND & STOCKTON LLP2 EMBARCADERO CTRSUITE 1900SAN FRANCISCO, CA 94111-3833Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use | ABANDONED | — |
| 005 | Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use | ABANDONED | — |
| 035 | Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits | ABANDONED | — |
| 040 | Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits | ABANDONED | — |
| 042 | medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ATGen Co., Ltd.
- Other trademarks owned by ATGen Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ATGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 5, 2019 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Feb 5, 2019 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Feb 5, 2019 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Feb 5, 2019 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Dec 2, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 22, 2015 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jun 22, 2015 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 26, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 14, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 18, 2014 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 17, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 7, 2014 | NWAP | NEW APPLICATION ENTERED | — |